Patents by Inventor Alan Hayter

Alan Hayter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170185748
    Abstract: Systems, methods and apparatus are provided for estimating meal start and peak meal response times are provided based on time series of sampled glucose data collected. Numerous additional aspects are disclosed.
    Type: Application
    Filed: March 30, 2015
    Publication date: June 29, 2017
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Erwin Satrya Budiman, Gary Alan Hayter
  • Patent number: 9675290
    Abstract: Methods, devices, systems, and computer program products are provided to improve sensitivity calibration of an in vivo analyte sensor and usability of an associated analyte monitoring system. In certain embodiments, methods are provided that improve the user experience of using an analyte monitoring system. Certain embodiments of the present disclosure include features that reduce the amount of calibration or re-calibration performed by the analyte monitoring system. More specifically methods of using a suspect calibration attempt to avoid having to recalibrate by adjusting the calibration or mitigating effects of sensor signal attenuation that caused the calibration attempt to be suspect are provided. Additional features are disclosed.
    Type: Grant
    Filed: October 29, 2013
    Date of Patent: June 13, 2017
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Erwin Satrya Budiman, Gary Alan Hayter
  • Patent number: 9669162
    Abstract: Method and system for providing basal profile modification in insulin therapy for use with infusion devices includes periodically monitoring the analyte levels of a patient for a predetermined period of time in order to determine, based on the monitored analyte levels, an appropriate modification factor to be incorporated into the underlying basal profile which was running at the time the periodic monitoring of the analyte levels were performed.
    Type: Grant
    Filed: March 16, 2016
    Date of Patent: June 6, 2017
    Inventors: Mark Kent Sloan, Gary Alan Hayter
  • Publication number: 20170124287
    Abstract: Methods and apparatus for analyte level estimation are provided.
    Type: Application
    Filed: January 18, 2017
    Publication date: May 4, 2017
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Gary Alan Hayter, Erwin Satrya Budiman
  • Patent number: 9629578
    Abstract: Methods and apparatuses for determining an analyte value are disclosed.
    Type: Grant
    Filed: March 26, 2016
    Date of Patent: April 25, 2017
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Gary Alan Hayter, Erwin Satrya Budiman, Kenneth J. Doniger, John Charles Mazza
  • Patent number: 9610046
    Abstract: Methods, system and devices for monitoring control parameters in a closed loop control operation including continuously monitoring glucose level and automatic administration of a medication, detecting a condition associated with hypoglycemia, determining whether a probability of the detected condition associated with hypoglycemia exceeding a threshold level, and outputting a notification based upon the determination are provided.
    Type: Grant
    Filed: April 29, 2014
    Date of Patent: April 4, 2017
    Inventor: Gary Alan Hayter
  • Publication number: 20170086756
    Abstract: Embodiments described herein relate to an analyte monitoring device having a user interface with a display and a plurality of actuators. The display is configured to render a plurality of display screens, including a home screen and an alert screen. The home screen is divided into a plurality of simultaneously displayed panels, with a first panel displays a rate of change of continuously monitored analyte levels in interstitial fluid, a second panel simultaneously displays a current analyte level and an analyte trend indicator, and a third panel displays status information of a plurality of components of the device. When an alarm condition is detected, the display renders the alert screen in place of the home screen, the alert screen displaying information corresponding to the detected alarm condition. Furthermore, the actuators are configured to affect further output of the analyte monitoring device corresponding to the detected condition.
    Type: Application
    Filed: December 13, 2016
    Publication date: March 30, 2017
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Wesley Scott Harper, Annie C. Tan, Timothy Christian Dunn, Mark Kent Sloan, Kenneth J. Doniger, Michael Love, Phillip Yee, Gary Alan Hayter, R. Curtis Jennewine, Glenn Howard Berman
  • Publication number: 20170049369
    Abstract: Method and apparatus for providing calibration of analyte sensor including applying a control signal, detecting a measured response to the control signal, determining a variance in the detected measured response, and estimating a sensor sensitivity based on the variance in the detected measured response is provided
    Type: Application
    Filed: November 4, 2016
    Publication date: February 23, 2017
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Gary Alan Hayter, Kenneth J. Doniger, Erwin Satrya Budiman, Songbiao Zhang, John Charles Mazza
  • Patent number: 9572934
    Abstract: Method of monitoring a control operation of a medication delivery system, determining whether a signal level received from an analyte sensor is associated with a fault condition and a potential fault condition, and adjusting a medication delivery rate executed by the control operation when it is determined that the signal level from the analyte sensor is associated with one of the fault condition or the potential fault condition, where the medication delivery rate is adjusted to a first predetermined range when the signal level is associated with the fault condition, and adjusted to a second predetermined range when the signal level is associated with the potential fault condition is provided. Devices, systems and kits for implementing the afore-mentioned method are also provided.
    Type: Grant
    Filed: August 1, 2014
    Date of Patent: February 21, 2017
    Assignee: Abbott DiabetesCare Inc.
    Inventor: Gary Alan Hayter
  • Publication number: 20170027484
    Abstract: Methods and apparatus for providing data processing and control for use in a medical communication system are provided.
    Type: Application
    Filed: October 15, 2016
    Publication date: February 2, 2017
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Gary Alan Hayter, Geoffrey V. McGarraugh
  • Patent number: 9558325
    Abstract: Methods and apparatus for analyte level estimation are provided for filtering measurement data. In an embodiment, a present predicted analyte level estimate is determined. A present corrected analyte level estimate is determined based at least in part on the determined present predicted analyte level estimate and a received present monitored analyte measurement data. One or more of the medication infusion rate or the received present monitored analyte measurement data are filtered using a rate variance filter, wherein when the medication infusion rate exceeds a predetermined threshold level, the rate variance filter is adjusted from a predetermined setting to a modified setting to be responsive to changes in the present monitored analyte measurement data after a predetermined time period lapses.
    Type: Grant
    Filed: June 24, 2013
    Date of Patent: January 31, 2017
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Gary Alan Hayter, Erwin Satrya Budiman
  • Patent number: 9549694
    Abstract: Embodiments described herein relate to an analyte monitoring device having a user interface with a display and a plurality of actuators. The display is configured to render a plurality of display screens, including a home screen and an alert screen. The home screen is divided into a plurality of simultaneously displayed panels, with a first panel displays a rate of change of continuously monitored analyte levels in interstitial fluid, a second panel simultaneously displays a current analyte level and an analyte trend indicator, and a third panel displays status information of a plurality of components of the device. When an alarm condition is detected, the display renders the alert screen in place of the home screen, the alert screen displaying information corresponding to the detected alarm condition. Furthermore, the actuators are configured to affect further output of the analyte monitoring device corresponding to the detected condition.
    Type: Grant
    Filed: November 11, 2015
    Date of Patent: January 24, 2017
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Wesley Scott Harper, Annie C. Tan, Timothy Christian Dunn, Mark Kent Sloan, Kenneth J. Doniger, Michael Love, Phillip Yee, Gary Alan Hayter, R. Curtis Jennewine, Glenn Howard Berman
  • Publication number: 20170000426
    Abstract: Embodiments described herein relate to an analyte monitoring device having a user interface with a display and a plurality of actuators. The display is configured to render a plurality of display screens, including a home screen and an alert screen. The home screen is divided into a plurality of simultaneously displayed panels, with a first panel displays a rate of change of continuously monitored analyte levels in interstitial fluid, a second panel simultaneously displays a current analyte level and an analyte trend indicator, and a third panel displays status information of a plurality of components of the device. When an alarm condition is detected, the display renders the alert screen in place of the home screen, the alert screen displaying information corresponding to the detected alarm condition. Furthermore, the actuators are configured to affect further output of the analyte monitoring device corresponding to the detected condition.
    Type: Application
    Filed: September 8, 2016
    Publication date: January 5, 2017
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Wesley Scott Harper, Annie C. Tan, Timothy Christian Dunn, Mark Kent Sloan, Kenneth J. Doniger, Michael Love, Phillip Yee, Gary Alan Hayter, R. Curtis Jennewine, Glenn Howard Berman
  • Publication number: 20160317069
    Abstract: Method and apparatus for providing calibration of analyte sensor including applying a control signal, detecting a measured response to the control signal, determining a variance in the detected measured response, and estimating a sensor sensitivity based on the variance in the detected measured response is provided
    Type: Application
    Filed: July 13, 2016
    Publication date: November 3, 2016
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Gary Alan Hayter, Kenneth J. Doniger, Erwin Satrya Budiman, Songbiao Zhang, John Charles Mazza
  • Patent number: 9483608
    Abstract: Methods and apparatus for providing data processing and control for use in a medical communication system are provided.
    Type: Grant
    Filed: May 20, 2013
    Date of Patent: November 1, 2016
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Gary Alan Hayter, Geoffrey V. McGarraugh
  • Publication number: 20160296148
    Abstract: Methods and apparatus for providing data processing and control for use in verifying the stability of sensor sensitivity of an analyte sensor.
    Type: Application
    Filed: June 22, 2016
    Publication date: October 13, 2016
    Inventors: Gary Alan Hayter, Geoffrey V. McGarraugh, Andrew H. Naegeli, John Charles Mazza, Benjamin Jay Feldman, Wesley Scott Harper
  • Publication number: 20160245791
    Abstract: In particular embodiments, methods, devices and systems including calibrating analyte data associated with a monitored analyte level received from an analyte sensor based on a reference measurement, determining a lag time constant associated with the calibrated analyte data, and performing lag correction of the calibrated analyte data based on the determined time lag constant are disclosed.
    Type: Application
    Filed: April 29, 2016
    Publication date: August 25, 2016
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Gary Alan Hayter, Kenneth J. Doniger, Erwin Satrya Budiman
  • Publication number: 20160238589
    Abstract: The present disclosure provides methods of processing data provided by a transcutaneous or subcutaneous analyte sensor utilizing different algorithms to strike a balance between signal responsiveness accompanied by signal noise and the introduction of error associated with that noise. The methods utilize the strengths of a lag correction algorithm and a smoothing algorithm to optimize the quality and value of the resulting data (glucose concentrations and the rates of change in glucose concentrations) to a continuous glucose monitoring system. Also provided are systems and kits.
    Type: Application
    Filed: April 29, 2016
    Publication date: August 18, 2016
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Wesley Scott Harper, Erwin Satrya Budiman, Kenneth J. Doniger, Gary Alan Hayter
  • Patent number: 9408566
    Abstract: Method and apparatus for providing calibration of analyte sensor including applying a control signal, detecting a measured response to the control signal, determining a variance in the detected measured response, and estimating a sensor sensitivity based on the variance in the detected measured response is provided.
    Type: Grant
    Filed: February 13, 2013
    Date of Patent: August 9, 2016
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Gary Alan Hayter, Kenneth J. Doniger, Erwin Satrya Budiman, Songbiao Zhang, John Charles Mazza
  • Publication number: 20160220189
    Abstract: Methods and devices and systems for determining an analyte value are disclosed.
    Type: Application
    Filed: April 8, 2016
    Publication date: August 4, 2016
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: GARY ALAN HAYTER, KENNETH J. DONIGER, ERWIN SATRYA BUDIMAN